NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Clinical trials for NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) explained in plain language.
Never miss a new study
Get alerted when new NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC) trials appear
Sign up with your email to follow new studies for NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive new cancer drug targeting specific tumor mutations
Disease control Recruiting nowThis is the first study in people testing a new cancer drug called KO-2806. It aims to find a safe dose and see if the drug can help control advanced solid tumors, including certain lung, colorectal, pancreatic, and kidney cancers. The study will test the drug by itself and combi…
Matched conditions: NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New cancer drug combo trial seeks to control advanced tumors
Disease control Recruiting nowThis study is testing a new drug called XL092, both by itself and in combination with other immunotherapy drugs, for people with advanced solid tumors that cannot be removed by surgery. The main goals are to find safe doses and see if the treatments can shrink tumors or slow thei…
Matched conditions: NON CLEAR CELL RENAL CELL CARCINOMA (NCCRCC)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC